Adcetris (brentuximab vedotin) supply for hospitals & distributors
CD30-directed antibody–drug conjugate · Takeda (Pfizer / Seagen in the US and Canada)
Adcetris (brentuximab vedotin) is a CD30-directed antibody–drug conjugate carrying the microtubule inhibitor MMAE. It is marketed by Takeda outside the US and Canada and is supplied as a lyophilised powder for IV infusion.
Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.
Product facts
Strengths and presentation
- 50 mg powder for concentrate for solution for infusion, single-use vial
Approved indications (EMA / FDA label summary)
- CD30+ classical Hodgkin lymphoma — first-line with AVD, relapsed/refractory, and post-transplant consolidation
- Systemic anaplastic large cell lymphoma (first-line with CHP, and relapsed/refractory)
- CD30+ peripheral T-cell lymphoma, first-line with CHP (label-dependent)
- CD30+ cutaneous T-cell lymphoma after prior systemic therapy
Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.
Storage and cold chain
- Store refrigerated at 2–8 °C in the original carton to protect from light
- Do not freeze; do not shake
- Shipped in validated cold-chain packaging with temperature data logging
How we supply
- Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
- Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
- Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
- Validated 2–8 °C cold-chain shipping with a temperature data logger from origin to handover.
- Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.
Procurement notes
Adcetris is dosed by body weight (1.2 or 1.8 mg/kg depending on regimen, with a dose cap), so most adult cycles need two to three 50 mg vials. Share the regimen and weight band and we will quote the vial count per cycle.
Who we supply
- Hospital pharmacy and procurement departments
- Licensed pharmaceutical distributors and importers
- Oncology and haematology centres
- Treating physicians arranging named-patient supply
Markets served
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.
Frequently asked questions
How many Adcetris vials does a cycle need?
It depends on body weight and regimen. As a guide, most adult cycles use two to three 50 mg vials; the treating pharmacy confirms the exact count.
Who is the manufacturer of the Adcetris you supply?
Packs sourced from Turkish and European wholesalers are Takeda-marketed Adcetris in the original carton, with batch and expiry confirmed before dispatch.
Is the Adcetris you supply an original manufacturer pack?
Yes. We supply Adcetris only in the original Takeda (Pfizer / Seagen in the US and Canada) pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
Which documents come with a consignment?
Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.
Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?
Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.
How do I get a quote for Adcetris?
Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.
Send a supply inquiry
Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.
Send a supply inquiryOther medicines we supply to the Gulf
- Keytruda (pembrolizumab)
- Opdivo (nivolumab)
- Enhertu (trastuzumab deruxtecan)
- Tagrisso (osimertinib)
- Darzalex (daratumumab)
- Imfinzi (durvalumab)
- Tecentriq (atezolizumab)
- Perjeta (pertuzumab)
- Kadcyla (trastuzumab emtansine)
- Lynparza (olaparib)
- Revlimid (lenalidomide)
- Imbruvica (ibrutinib)
- Venclyxto (venetoclax)
- Xtandi (enzalutamide)
Sources
Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04